Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

T cell receptor repertoires after adoptive transfer of expanded allogeneic regulatory T cells.

Theil A, Wilhelm C, Kuhn M, Petzold A, Tuve S, Oelschlägel U, Dahl A, Bornhäuser M, Bonifacio E, Eugster A.

Clin Exp Immunol. 2017 Feb;187(2):316-324. doi: 10.1111/cei.12887. Epub 2016 Nov 27.

2.

Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q.

Balaian E, Schuster C, Schönefeldt C, Germing U, Haase D, Tuve S, Ordemann R, Ehninger G, Bornhäuser M, Oelschlaegel U, Mohr B, von Bonin M, Platzbecker U, Wermke M.

Ann Hematol. 2016 Oct;95(11):1805-10. doi: 10.1007/s00277-016-2775-y. Epub 2016 Aug 10.

PMID:
27510179
3.

Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease.

Theil A, Tuve S, Oelschlägel U, Maiwald A, Döhler D, Oßmann D, Zenkel A, Wilhelm C, Middeke JM, Shayegi N, Trautmann-Grill K, von Bonin M, Platzbecker U, Ehninger G, Bonifacio E, Bornhäuser M.

Cytotherapy. 2015 Apr;17(4):473-86. doi: 10.1016/j.jcyt.2014.11.005. Epub 2015 Jan 6.

PMID:
25573333
4.

Proinflammatory human 6-sulfo LacNAc-positive dendritic cells accumulate in intestinal acute graft-versus-host disease.

Sommer U, Larsson B, Tuve S, Wehner R, Zimmermann N, Kramer M, Kloβ A, Günther C, Babatz J, Schmelz R, Brückner S, Schetelig J, Bornhäuser M, Schäkel K, Bachmann MP, Aust D, Baretton G, Schmitz M.

Haematologica. 2014 Jun;99(6):e86-9. doi: 10.3324/haematol.2013.101071. Epub 2014 Mar 28. No abstract available.

5.

Reconstitution of interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation.

Bahr F, Wehner R, Platzbecker U, Wermke M, Shayegi N, Middeke JM, Röllig C, Schetelig J, Ehninger G, Schmitz M, Bornhäuser M, Tuve S.

Biol Blood Marrow Transplant. 2013 Mar;19(3):357-65. doi: 10.1016/j.bbmt.2012.11.018. Epub 2012 Nov 30.

6.

Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation.

Icheva V, Kayser S, Wolff D, Tuve S, Kyzirakos C, Bethge W, Greil J, Albert MH, Schwinger W, Nathrath M, Schumm M, Stevanovic S, Handgretinger R, Lang P, Feuchtinger T.

J Clin Oncol. 2013 Jan 1;31(1):39-48. doi: 10.1200/JCO.2011.39.8495. Epub 2012 Nov 19.

PMID:
23169501
7.

Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation.

Mager K, Wehner R, Bahr F, Oelschlägel U, Platzbecker U, Wermke M, Shayegi N, Middeke JM, Radke J, Röllig C, Schetelig J, Thiede C, Ehninger G, Schmitz M, Bornhäuser M, Tuve S.

Transplantation. 2012 Jun 27;93(12):1270-5. doi: 10.1097/TP.0b013e31824fd8b4.

PMID:
22643330
8.

Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia.

Bornhäuser M, Thiede C, Platzbecker U, Kiani A, Oelschlaegel U, Babatz J, Lehmann D, Hölig K, Radke J, Tuve S, Wermke M, Wehner R, Jähnisch H, Bachmann MP, Rieber EP, Schetelig J, Ehninger G, Schmitz M.

Blood. 2011 Jun 30;117(26):7174-84. doi: 10.1182/blood-2010-09-308569. Epub 2011 May 3.

PMID:
21540460
9.

Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse models.

Liu Y, Tuve S, Persson J, Beyer I, Yumul R, Li ZY, Tragoolpua K, Hellström KE, Roffler S, Lieber A.

Cancer Gene Ther. 2011 Jun;18(6):407-18. doi: 10.1038/cgt.2011.8. Epub 2011 Mar 11.

10.

Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategy.

Tuve S, Gayoso J, Scheid C, Radke J, Kiani A, Serrano D, Platzbecker U, Rodríguez-Macías G, Wermke M, Holtick U, Balsalobre P, Middeke JM, Shayegi N, Chemnitz JM, Krause A, Gruner N, Füssel M, Schetelig J, Thiede C, Ehninger G, Hallek M, Díez-Martín JL, Bornhäuser M.

Leukemia. 2011 May;25(5):880-3. doi: 10.1038/leu.2011.11. Epub 2011 Feb 11. No abstract available.

PMID:
21311556
11.

Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses.

Strauss R, Sova P, Liu Y, Li ZY, Tuve S, Pritchard D, Brinkkoetter P, Möller T, Wildner O, Pesonen S, Hemminki A, Urban N, Drescher C, Lieber A.

Cancer Res. 2009 Jun 15;69(12):5115-25. doi: 10.1158/0008-5472.CAN-09-0645. Epub 2009 Jun 2.

12.

In situ adenovirus vaccination engages T effector cells against cancer.

Tuve S, Liu Y, Tragoolpua K, Jacobs JD, Yumul RC, Li ZY, Strauss R, Hellström KE, Disis ML, Roffler S, Lieber A.

Vaccine. 2009 Jun 24;27(31):4225-39. doi: 10.1016/j.vaccine.2009.03.074. Epub 2009 Apr 16.

13.

Toward a stem cell gene therapy for breast cancer.

Li Z, Liu Y, Tuve S, Xun Y, Fan X, Min L, Feng Q, Kiviat N, Kiem HP, Disis ML, Lieber A.

Blood. 2009 May 28;113(22):5423-33. doi: 10.1182/blood-2008-10-187237. Epub 2009 Mar 27.

14.

Receptor usage of a newly emergent adenovirus type 14.

Wang H, Tuve S, Erdman DD, Lieber A.

Virology. 2009 May 10;387(2):436-41. doi: 10.1016/j.virol.2009.02.034.

15.

Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35.

Tuve S, Wang H, Jacobs JD, Yumul RC, Smith DF, Lieber A.

PLoS Pathog. 2008 Oct;4(10):e1000189. doi: 10.1371/journal.ppat.1000189. Epub 2008 Oct 31.

16.

In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46.

Wang H, Liu Y, Li Z, Tuve S, Stone D, Kalyushniy O, Shayakhmetov D, Verlinde CL, Stehle T, McVey J, Baker A, Peng KW, Roffler S, Lieber A.

J Virol. 2008 Nov;82(21):10567-79. doi: 10.1128/JVI.01308-08. Epub 2008 Aug 27.

17.

Identification of CD46 binding sites within the adenovirus serotype 35 fiber knob.

Wang H, Liaw YC, Stone D, Kalyuzhniy O, Amiraslanov I, Tuve S, Verlinde CL, Shayakhmetov D, Stehle T, Roffler S, Lieber A.

J Virol. 2007 Dec;81(23):12785-92. Epub 2007 Sep 26.

18.

Comparison of adenoviruses from species B, C, E, and F after intravenous delivery.

Stone D, Liu Y, Li ZY, Tuve S, Strauss R, Lieber A.

Mol Ther. 2007 Dec;15(12):2146-53. Epub 2007 Sep 25.

19.

Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses.

Tuve S, Chen BM, Liu Y, Cheng TL, Touré P, Sow PS, Feng Q, Kiviat N, Strauss R, Ni S, Li ZY, Roffler SR, Lieber A.

Cancer Res. 2007 Jun 15;67(12):5929-39.

20.

Baculovirus-based vaccination vectors allow for efficient induction of immune responses against plasmodium falciparum circumsporozoite protein.

Strauss R, Hüser A, Ni S, Tuve S, Kiviat N, Sow PS, Hofmann C, Lieber A.

Mol Ther. 2007 Jan;15(1):193-202.

21.

A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells.

Tuve S, Wang H, Ware C, Liu Y, Gaggar A, Bernt K, Shayakhmetov D, Li Z, Strauss R, Stone D, Lieber A.

J Virol. 2006 Dec;80(24):12109-20. Epub 2006 Oct 4.

22.

Adenovirus-mediated TA-p73beta gene transfer increases chemosensitivity of human malignant melanomas.

Tuve S, Racek T, Niemetz A, Schultz J, Soengas MS, Pützer BM.

Apoptosis. 2006 Feb;11(2):235-43.

23.

Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination.

DiPaolo N, Ni S, Gaggar A, Strauss R, Tuve S, Li ZY, Stone D, Shayakhmetov D, Kiviat N, Touré P, Sow S, Horvat B, Lieber A.

Mol Ther. 2006 Apr;13(4):756-65. Epub 2006 Feb 7.

24.
25.

Quantitative TP73 transcript analysis in hepatocellular carcinomas.

Stiewe T, Tuve S, Peter M, Tannapfel A, Elmaagacli AH, Pützer BM.

Clin Cancer Res. 2004 Jan 15;10(2):626-33.

26.

Alterations of DeltaTA-p 73 splice transcripts during melanoma development and progression.

Tuve S, Wagner SN, Schittek B, Pützer BM.

Int J Cancer. 2004 Jan 1;108(1):162-6.

27.

Increased DeltaN-p73 expression in tumors by upregulation of the E2F1-regulated, TA-promoter-derived DeltaN'-p73 transcript.

Pützer BM, Tuve S, Tannapfel A, Stiewe T.

Cell Death Differ. 2003 May;10(5):612-4. No abstract available.

Supplemental Content

Support Center